negative regulation of transcription by RNA polymerase II | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of transcription by RNA polymerase II | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to lipopolysaccharide | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of transcription by RNA polymerase II | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
regulation of transcription by RNA polymerase II | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
transcription by RNA polymerase II | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
apoptotic process | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
inflammatory response | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
canonical NF-kappaB signal transduction | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
JNK cascade | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of gene expression | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of macrophage derived foam cell differentiation | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of lipid storage | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of calcidiol 1-monooxygenase activity | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of vitamin D biosynthetic process | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of cholesterol transport | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of interleukin-12 production | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
response to muscle stretch | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
non-canonical NF-kappaB signal transduction | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of apoptotic process | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of DNA-templated transcription | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of transcription by RNA polymerase II | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of inflammatory response | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
B cell receptor signaling pathway | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
negative regulation of protein metabolic process | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
mammary gland involution | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of transcription initiation by RNA polymerase II | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to mechanical stimulus | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to nicotine | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to interleukin-1 | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to interleukin-6 | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to tumor necrosis factor | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to dsRNA | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of canonical Wnt signaling pathway | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to interleukin-17 | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to virus | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
antibacterial innate immune response | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of hyaluronan biosynthetic process | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to angiotensin | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
positive regulation of miRNA metabolic process | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
cellular response to stress | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
innate immune response | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
response to cytokine | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) |
follicular dendritic cell differentiation | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
germinal center formation | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
regulation of DNA-templated transcription | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
canonical NF-kappaB signal transduction | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
extracellular matrix organization | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
response to lipopolysaccharide | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
positive regulation of transcription by RNA polymerase II | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
rhythmic process | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
spleen development | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
cellular response to stress | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
innate immune response | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
non-canonical NF-kappaB signal transduction | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
response to cytokine | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
inflammatory response | Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) |
positive regulation of interleukin-1 beta production | Transcription factor p65 | Homo sapiens (human) |
positive regulation of interleukin-6 production | Transcription factor p65 | Homo sapiens (human) |
positive regulation of interleukin-8 production | Transcription factor p65 | Homo sapiens (human) |
positive regulation of amyloid-beta formation | Transcription factor p65 | Homo sapiens (human) |
positive regulation of NF-kappaB transcription factor activity | Transcription factor p65 | Homo sapiens (human) |
nucleotide-binding oligomerization domain containing 2 signaling pathway | Transcription factor p65 | Homo sapiens (human) |
negative regulation of transcription by RNA polymerase II | Transcription factor p65 | Homo sapiens (human) |
liver development | Transcription factor p65 | Homo sapiens (human) |
hair follicle development | Transcription factor p65 | Homo sapiens (human) |
defense response to tumor cell | Transcription factor p65 | Homo sapiens (human) |
response to ischemia | Transcription factor p65 | Homo sapiens (human) |
acetaldehyde metabolic process | Transcription factor p65 | Homo sapiens (human) |
chromatin organization | Transcription factor p65 | Homo sapiens (human) |
DNA-templated transcription | Transcription factor p65 | Homo sapiens (human) |
regulation of DNA-templated transcription | Transcription factor p65 | Homo sapiens (human) |
regulation of transcription by RNA polymerase II | Transcription factor p65 | Homo sapiens (human) |
inflammatory response | Transcription factor p65 | Homo sapiens (human) |
cellular defense response | Transcription factor p65 | Homo sapiens (human) |
neuropeptide signaling pathway | Transcription factor p65 | Homo sapiens (human) |
canonical NF-kappaB signal transduction | Transcription factor p65 | Homo sapiens (human) |
positive regulation of cell population proliferation | Transcription factor p65 | Homo sapiens (human) |
response to xenobiotic stimulus | Transcription factor p65 | Homo sapiens (human) |
animal organ morphogenesis | Transcription factor p65 | Homo sapiens (human) |
response to UV-B | Transcription factor p65 | Homo sapiens (human) |
positive regulation of vascular endothelial growth factor production | Transcription factor p65 | Homo sapiens (human) |
positive regulation of gene expression | Transcription factor p65 | Homo sapiens (human) |
positive regulation of Schwann cell differentiation | Transcription factor p65 | Homo sapiens (human) |
negative regulation of angiogenesis | Transcription factor p65 | Homo sapiens (human) |
cytokine-mediated signaling pathway | Transcription factor p65 | Homo sapiens (human) |
protein catabolic process | Transcription factor p65 | Homo sapiens (human) |
response to muramyl dipeptide | Transcription factor p65 | Homo sapiens (human) |
response to progesterone | Transcription factor p65 | Homo sapiens (human) |
positive regulation of interleukin-12 production | Transcription factor p65 | Homo sapiens (human) |
positive regulation of interleukin-6 production | Transcription factor p65 | Homo sapiens (human) |
positive regulation of interleukin-8 production | Transcription factor p65 | Homo sapiens (human) |
response to insulin | Transcription factor p65 | Homo sapiens (human) |
tumor necrosis factor-mediated signaling pathway | Transcription factor p65 | Homo sapiens (human) |
negative regulation of protein sumoylation | Transcription factor p65 | Homo sapiens (human) |
response to cobalamin | Transcription factor p65 | Homo sapiens (human) |
toll-like receptor 4 signaling pathway | Transcription factor p65 | Homo sapiens (human) |
intracellular signal transduction | Transcription factor p65 | Homo sapiens (human) |
cellular response to hepatocyte growth factor stimulus | Transcription factor p65 | Homo sapiens (human) |
response to muscle stretch | Transcription factor p65 | Homo sapiens (human) |
non-canonical NF-kappaB signal transduction | Transcription factor p65 | Homo sapiens (human) |
vascular endothelial growth factor signaling pathway | Transcription factor p65 | Homo sapiens (human) |
prolactin signaling pathway | Transcription factor p65 | Homo sapiens (human) |
negative regulation of protein catabolic process | Transcription factor p65 | Homo sapiens (human) |
negative regulation of apoptotic process | Transcription factor p65 | Homo sapiens (human) |
positive regulation of canonical NF-kappaB signal transduction | Transcription factor p65 | Homo sapiens (human) |
response to amino acid | Transcription factor p65 | Homo sapiens (human) |
negative regulation of DNA-templated transcription | Transcription factor p65 | Homo sapiens (human) |
positive regulation of DNA-templated transcription | Transcription factor p65 | Homo sapiens (human) |
positive regulation of transcription by RNA polymerase II | Transcription factor p65 | Homo sapiens (human) |
negative regulation of insulin receptor signaling pathway | Transcription factor p65 | Homo sapiens (human) |
regulation of inflammatory response | Transcription factor p65 | Homo sapiens (human) |
positive regulation of T cell receptor signaling pathway | Transcription factor p65 | Homo sapiens (human) |
positive regulation of NF-kappaB transcription factor activity | Transcription factor p65 | Homo sapiens (human) |
response to cAMP | Transcription factor p65 | Homo sapiens (human) |
defense response to virus | Transcription factor p65 | Homo sapiens (human) |
cellular response to hydrogen peroxide | Transcription factor p65 | Homo sapiens (human) |
interleukin-1-mediated signaling pathway | Transcription factor p65 | Homo sapiens (human) |
response to interleukin-1 | Transcription factor p65 | Homo sapiens (human) |
cellular response to lipopolysaccharide | Transcription factor p65 | Homo sapiens (human) |
cellular response to lipoteichoic acid | Transcription factor p65 | Homo sapiens (human) |
cellular response to peptidoglycan | Transcription factor p65 | Homo sapiens (human) |
cellular response to nicotine | Transcription factor p65 | Homo sapiens (human) |
cellular response to interleukin-1 | Transcription factor p65 | Homo sapiens (human) |
cellular response to interleukin-6 | Transcription factor p65 | Homo sapiens (human) |
cellular response to tumor necrosis factor | Transcription factor p65 | Homo sapiens (human) |
postsynapse to nucleus signaling pathway | Transcription factor p65 | Homo sapiens (human) |
antiviral innate immune response | Transcription factor p65 | Homo sapiens (human) |
negative regulation of non-canonical NF-kappaB signal transduction | Transcription factor p65 | Homo sapiens (human) |
positive regulation of non-canonical NF-kappaB signal transduction | Transcription factor p65 | Homo sapiens (human) |
negative regulation of miRNA transcription | Transcription factor p65 | Homo sapiens (human) |
positive regulation of miRNA transcription | Transcription factor p65 | Homo sapiens (human) |
cellular response to angiotensin | Transcription factor p65 | Homo sapiens (human) |
positive regulation of leukocyte adhesion to vascular endothelial cell | Transcription factor p65 | Homo sapiens (human) |
positive regulation of miRNA metabolic process | Transcription factor p65 | Homo sapiens (human) |
negative regulation of extrinsic apoptotic signaling pathway | Transcription factor p65 | Homo sapiens (human) |
cellular response to stress | Transcription factor p65 | Homo sapiens (human) |
response to cytokine | Transcription factor p65 | Homo sapiens (human) |
innate immune response | Transcription factor p65 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |